Literature DB >> 11098984

Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services.

M I Rudis1, K M Brandl.   

Abstract

OBJECTIVE: The goal of the Task Force on Critical Care Pharmacy Services was to identify and describe the scope of practice that characterizes the critical care pharmacist and critical care pharmacy services. Specifically, the aims were to define the level of clinical practice and specialized skills characterizing the critical care pharmacist as clinician, educator, researcher, and manager; and to recommend fundamental, desirable, and optimal pharmacy services and personnel requirements for the provision of pharmaceutical care to critically ill patients. Hospitals having comprehensive resources as well as those with more limited resources were considered. DATA SOURCES: Consensus opinion of critical care pharmacists from institutions of various sizes providing critical care services within several types of pharmacy practice models was obtained, including community-based and academic practice settings. Existing guidelines and literature describing pharmacy practice and medication use processes were reviewed and adapted for the critical care setting.
CONCLUSIONS: By combining the strengths and expertise of critical care pharmacy specialists with existing supporting literature, these recommendations define the level of clinical practice and specialized skills that characterize the critical care pharmacist as clinician, educator, researcher, and manager. This Position Paper recommends fundamental, desirable, and optimal pharmacy services as well as personnel requirements for the provision of pharmaceutical care to critically ill patients.

Entities:  

Mesh:

Year:  2000        PMID: 11098984     DOI: 10.1097/00003246-200011000-00037

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  30 in total

1.  How critical are critical care pharmacists?

Authors:  Clarence Chant
Journal:  Can J Hosp Pharm       Date:  2012-01

2.  [Not Available].

Authors:  Clarence Chant
Journal:  Can J Hosp Pharm       Date:  2012-01

3.  Transitioning knowledge gained from simulation to pharmacy practice.

Authors:  Sandra L Kane-Gill; Pamela L Smithburger
Journal:  Am J Pharm Educ       Date:  2011-12-15       Impact factor: 2.047

4.  International critical care hospital pharmacist activities.

Authors:  Jaclyn M LeBlanc; Enrique C Seoane-Vazquez; Trudy C Arbo; Joseph F Dasta
Journal:  Intensive Care Med       Date:  2007-11-07       Impact factor: 17.440

5.  How to increase return on investment of the intensive care pharmacist - fear of flying.

Authors:  Michael Hartmann; Andreas Meier-Hellmann
Journal:  Intensive Care Med       Date:  2006-02-16       Impact factor: 17.440

Review 6.  Medication errors in critical care: risk factors, prevention and disclosure.

Authors:  Eric Camiré; Eric Moyen; Henry Thomas Stelfox
Journal:  CMAJ       Date:  2009-04-28       Impact factor: 8.262

7.  Clinical pharmacists' interventions in a German university hospital.

Authors:  Claudia Langebrake; Heike Hilgarth
Journal:  Pharm World Sci       Date:  2010-01-19

8.  Do we need a pharmacist in the ICU?

Authors:  Clarence Chant; Norman F Dewhurst; Jan O Friedrich
Journal:  Intensive Care Med       Date:  2015-05-21       Impact factor: 17.440

9.  Critical Care PGY-2 Graduate Perceptions and Practices Regarding Residency Project Publication.

Authors:  Hira Shafeeq; Drayton A Hammond; Joseph M Swanson; Chenghui Li; John W Devlin
Journal:  Am J Pharm Educ       Date:  2019-03       Impact factor: 2.047

10.  Standards for Neurologic Critical Care Units: A Statement for Healthcare Professionals from The Neurocritical Care Society.

Authors:  Asma M Moheet; Sarah L Livesay; Tamer Abdelhak; Thomas P Bleck; Theresa Human; Navaz Karanjia; Amanda Lamer-Rosen; Joshua Medow; Paul A Nyquist; Axel Rosengart; Wade Smith; Michel T Torbey; Cherylee W J Chang
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.